Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) traded up 1.2% during mid-day trading on Thursday . The stock traded as high as $8.3811 and last traded at $8.28. 717,701 shares traded hands during trading, an increase of 30% from the average session volume of 551,962 shares. The stock had previously closed at $8.18.
Cybin Stock Performance
The company has a market capitalization of $1.23 billion and a price-to-earnings ratio of -59.14. The firm’s 50 day moving average price is $8.29 and its two-hundred day moving average price is $7.05.
About Cybin
Cybin Inc (OTCMKTS: CLXPF) is a biotechnology company focused on the research, development and commercialization of psychedelic-based therapeutics for the treatment of mental health and wellness disorders. The company leverages proprietary drug discovery platforms to design novel analogues of psilocybin and other psychoactive compounds. Its programs aim to improve the safety, bioavailability and manufacturability of these molecules while addressing conditions such as depression, anxiety and substance use disorders.
Cybin’s pipeline encompasses several clinical and preclinical stage candidates.
See Also
- Five stocks we like better than Cybin
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
